Burry Optimistic on Molina's Medical Cost Performance
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy MOH?
Source: stocktwits
- Medical Cost Performance Beat: Molina Healthcare's Q1 medical care ratio reached 91.1%, significantly exceeding expectations and helping to stabilize investor concerns about rising healthcare costs, demonstrating the company's effectiveness in managing medical expenses.
- Earnings Outlook Improvement: Burry anticipates Molina could return to over $20 EPS, although the $25 target may take 2-3 years to achieve, indicating a growing confidence in the company's long-term profitability.
- Investor Sentiment Shift: Following Molina's earnings report, retail sentiment surged from 'bullish' to 'extremely bullish', with a 550% increase in message volume within 24 hours, reflecting optimism about the company's future prospects.
- Policy Tailwind Impact: Recent confirmation by U.S. regulators of a 2.48% increase in 2027 Medicare Advantage payment rates is expected to add over $13 billion in funding to private Medicare Advantage plans, further supporting Molina's growth potential.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy MOH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on MOH
Wall Street analysts forecast MOH stock price to rise
14 Analyst Rating
3 Buy
9 Hold
2 Sell
Hold
Current: 151.000
Low
155.00
Averages
180.85
High
250.00
Current: 151.000
Low
155.00
Averages
180.85
High
250.00
About MOH
Molina Healthcare, Inc. is a provider of managed healthcare services under the Medicaid and Medicare programs, and through the state insurance marketplaces. The Company operates through four segments: Medicaid, Medicare, Marketplace and Other. The Medicaid, Medicare, and Marketplace segments represent the government-funded or sponsored programs under which it offers managed healthcare services. Medicaid provides healthcare and long-term services and support to low-income Americans. Medicare is a federal program that provides eligible persons aged 65 and over, and some disabled persons, with a variety of hospital, medical insurance, and prescription drug benefits. The Marketplace insurance exchanges allow individuals and small groups to purchase federally subsidized health insurance. It arranges healthcare services for its members through contracts with a network of providers, including independent physicians and physician groups, hospitals, ancillary providers, and pharmacies.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Burry Optimistic on Molina's Medical Cost Performance
- Medical Cost Performance Beat: Molina Healthcare's Q1 medical care ratio reached 91.1%, significantly exceeding expectations and helping to stabilize investor concerns about rising healthcare costs, demonstrating the company's effectiveness in managing medical expenses.
- Earnings Outlook Improvement: Burry anticipates Molina could return to over $20 EPS, although the $25 target may take 2-3 years to achieve, indicating a growing confidence in the company's long-term profitability.
- Investor Sentiment Shift: Following Molina's earnings report, retail sentiment surged from 'bullish' to 'extremely bullish', with a 550% increase in message volume within 24 hours, reflecting optimism about the company's future prospects.
- Policy Tailwind Impact: Recent confirmation by U.S. regulators of a 2.48% increase in 2027 Medicare Advantage payment rates is expected to add over $13 billion in funding to private Medicare Advantage plans, further supporting Molina's growth potential.
See More
IBM Fails to Raise Full-Year Guidance, Shares Drop
- IBM Earnings Miss: IBM reported Q1 earnings of $1.91 per share, beating the $1.81 forecast, yet failed to raise its full-year guidance, resulting in a 6% drop in shares, indicating market concerns over future growth prospects.
- Tesla's Mixed Results: Tesla's Q1 adjusted earnings were 41 cents per share, surpassing the 37 cents expected by analysts, but its revenue of $22.39 billion fell short of the $22.64 billion consensus, reflecting cautious market sentiment regarding sales growth.
- Texas Instruments Strong Outlook: Texas Instruments forecasts current-quarter earnings between $1.77 and $2.05 per share, significantly above the $1.57 consensus, leading to a 10% increase in shares, showcasing robust demand in the semiconductor sector.
- United Rentals Sales Forecast Boost: United Rentals raised its full-year sales forecast to a range of $16.9 billion to $17.4 billion, with shares jumping over 15%, indicating strong market momentum heading into the busy season.
See More
Molina Healthcare Shares Rise Following UnitedHealth's Strong Earnings
- Industry Confidence Boost: Molina Healthcare's shares rose 1.9% in the afternoon session as UnitedHealth Group reported stronger-than-expected first-quarter profits, reflecting a surge in investor confidence across the healthcare insurance sector.
- Volatility Insights: The stock has experienced 19 moves greater than 5% over the past year, indicating that today's increase is seen as significant by the market, although it does not fundamentally alter perceptions of Molina's business.
- Profitability Challenges: Molina's adjusted earnings of $1.84 per share fell 52.7% short of analyst expectations of $3.89, prompting the company to lower its 2025 adjusted earnings guidance by 26.3%, highlighting ongoing profitability issues.
- Long-term Investment Returns: Molina's stock is down 15.3% year-to-date, trading at $151.08, which is 54.5% below its 52-week high of $332, indicating that investors who bought $1,000 worth of shares five years ago would now see only $593.78.
See More
Molina Healthcare to Announce Q1 Earnings on April 22
- Earnings Announcement: Molina Healthcare (MOH) is set to release its Q1 2023 earnings on April 22 after market close, with a consensus EPS estimate of $1.94, reflecting a significant year-over-year decline of 68.1%, indicating potential profitability challenges for the company.
- Revenue Decline: The expected revenue for the quarter is $10.89 billion, down 2.3% year-over-year, highlighting the competitive pressures the company faces in the healthcare insurance market, particularly under the strain of Medicare Advantage plan profitability.
- Forecast Adjustments: Over the past three months, EPS estimates have seen no upward revisions and 14 downward adjustments, indicating a lack of confidence among analysts regarding the company's future earnings potential, while revenue estimates have also faced 9 downward revisions, exacerbating concerns about the company's financial health.
- Historical Performance Review: Over the last two years, Molina Healthcare has only beaten EPS estimates 50% of the time, while achieving a 100% success rate in beating revenue estimates, suggesting a mixed performance that may affect investor confidence in the company's future outlook.
See More
UnitedHealth Group Raises 2026 Profit Guidance After Strong Q1 Earnings
- Earnings Beat: UnitedHealth Group reported Q1 revenue of $111.72 billion, a 2% increase year-over-year, surpassing analysts' expectations of $109.57 billion, indicating strong performance in the health insurance market and likely boosting investor confidence.
- Guidance Upgrade: The management raised the 2026 earnings per share forecast from $17.10 to $17.35, with adjusted EPS expectations increasing from $17.75 to $18.25, reflecting a positive outlook on the company's future profitability.
- Market Share Dominance: UnitedHealth Group holds the largest share in the Medicaid market with a market cap of $315 billion, significantly outpacing competitors, and its free cash flow of $16 billion over the past year underscores its financial strength and competitive edge.
- Accelerated Tech Investments: The CEO stated that the company has refocused on U.S. healthcare and is ramping up investments in technology and AI, which are expected to enhance operational efficiency and service quality, thereby improving customer satisfaction and market share.
See More
CVS Health Rises 1.7%, Elevance Increases 2.2%, Cigna Gains 1%, Humana Climbs 3.5%, Molina Healthcare Advances 2.3%
CVS Health Performance: CVS Health reported a 1.7% increase in its performance metrics.
Elevance Health Growth: Elevance Health experienced a growth of 2.2% in its financial results.
Cigna's Financial Status: Cigna saw a 1% rise in its performance indicators.
Humana and Molina Health Care: Humana reported a 3.5% increase, while Molina Health Care experienced a 2.3% growth.
See More
Burry Optimistic on Molina's Medical Cost Performance
- Medical Cost Performance Beat: Molina Healthcare's Q1 medical care ratio reached 91.1%, significantly exceeding expectations and helping to stabilize investor concerns about rising healthcare costs, demonstrating the company's effectiveness in managing medical expenses.
- Earnings Outlook Improvement: Burry anticipates Molina could return to over $20 EPS, although the $25 target may take 2-3 years to achieve, indicating a growing confidence in the company's long-term profitability.
- Investor Sentiment Shift: Following Molina's earnings report, retail sentiment surged from 'bullish' to 'extremely bullish', with a 550% increase in message volume within 24 hours, reflecting optimism about the company's future prospects.
- Policy Tailwind Impact: Recent confirmation by U.S. regulators of a 2.48% increase in 2027 Medicare Advantage payment rates is expected to add over $13 billion in funding to private Medicare Advantage plans, further supporting Molina's growth potential.
See More
IBM Fails to Raise Full-Year Guidance, Shares Drop
- IBM Earnings Miss: IBM reported Q1 earnings of $1.91 per share, beating the $1.81 forecast, yet failed to raise its full-year guidance, resulting in a 6% drop in shares, indicating market concerns over future growth prospects.
- Tesla's Mixed Results: Tesla's Q1 adjusted earnings were 41 cents per share, surpassing the 37 cents expected by analysts, but its revenue of $22.39 billion fell short of the $22.64 billion consensus, reflecting cautious market sentiment regarding sales growth.
- Texas Instruments Strong Outlook: Texas Instruments forecasts current-quarter earnings between $1.77 and $2.05 per share, significantly above the $1.57 consensus, leading to a 10% increase in shares, showcasing robust demand in the semiconductor sector.
- United Rentals Sales Forecast Boost: United Rentals raised its full-year sales forecast to a range of $16.9 billion to $17.4 billion, with shares jumping over 15%, indicating strong market momentum heading into the busy season.
See More
Molina Healthcare Shares Rise Following UnitedHealth's Strong Earnings
- Industry Confidence Boost: Molina Healthcare's shares rose 1.9% in the afternoon session as UnitedHealth Group reported stronger-than-expected first-quarter profits, reflecting a surge in investor confidence across the healthcare insurance sector.
- Volatility Insights: The stock has experienced 19 moves greater than 5% over the past year, indicating that today's increase is seen as significant by the market, although it does not fundamentally alter perceptions of Molina's business.
- Profitability Challenges: Molina's adjusted earnings of $1.84 per share fell 52.7% short of analyst expectations of $3.89, prompting the company to lower its 2025 adjusted earnings guidance by 26.3%, highlighting ongoing profitability issues.
- Long-term Investment Returns: Molina's stock is down 15.3% year-to-date, trading at $151.08, which is 54.5% below its 52-week high of $332, indicating that investors who bought $1,000 worth of shares five years ago would now see only $593.78.
See More
Molina Healthcare to Announce Q1 Earnings on April 22
- Earnings Announcement: Molina Healthcare (MOH) is set to release its Q1 2023 earnings on April 22 after market close, with a consensus EPS estimate of $1.94, reflecting a significant year-over-year decline of 68.1%, indicating potential profitability challenges for the company.
- Revenue Decline: The expected revenue for the quarter is $10.89 billion, down 2.3% year-over-year, highlighting the competitive pressures the company faces in the healthcare insurance market, particularly under the strain of Medicare Advantage plan profitability.
- Forecast Adjustments: Over the past three months, EPS estimates have seen no upward revisions and 14 downward adjustments, indicating a lack of confidence among analysts regarding the company's future earnings potential, while revenue estimates have also faced 9 downward revisions, exacerbating concerns about the company's financial health.
- Historical Performance Review: Over the last two years, Molina Healthcare has only beaten EPS estimates 50% of the time, while achieving a 100% success rate in beating revenue estimates, suggesting a mixed performance that may affect investor confidence in the company's future outlook.
See More
UnitedHealth Group Raises 2026 Profit Guidance After Strong Q1 Earnings
- Earnings Beat: UnitedHealth Group reported Q1 revenue of $111.72 billion, a 2% increase year-over-year, surpassing analysts' expectations of $109.57 billion, indicating strong performance in the health insurance market and likely boosting investor confidence.
- Guidance Upgrade: The management raised the 2026 earnings per share forecast from $17.10 to $17.35, with adjusted EPS expectations increasing from $17.75 to $18.25, reflecting a positive outlook on the company's future profitability.
- Market Share Dominance: UnitedHealth Group holds the largest share in the Medicaid market with a market cap of $315 billion, significantly outpacing competitors, and its free cash flow of $16 billion over the past year underscores its financial strength and competitive edge.
- Accelerated Tech Investments: The CEO stated that the company has refocused on U.S. healthcare and is ramping up investments in technology and AI, which are expected to enhance operational efficiency and service quality, thereby improving customer satisfaction and market share.
See More
CVS Health Rises 1.7%, Elevance Increases 2.2%, Cigna Gains 1%, Humana Climbs 3.5%, Molina Healthcare Advances 2.3%
CVS Health Performance: CVS Health reported a 1.7% increase in its performance metrics.
Elevance Health Growth: Elevance Health experienced a growth of 2.2% in its financial results.
Cigna's Financial Status: Cigna saw a 1% rise in its performance indicators.
Humana and Molina Health Care: Humana reported a 3.5% increase, while Molina Health Care experienced a 2.3% growth.
See More
